Yusuf Ilhan

13PUBLICATIONS
68CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsRadiation therapyNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 27, 2026
Does the Duration of FLOT Infusion Change the Outcome of Perioperative Treatment for Gastric Cancer? Comparing 24- and 48-h Infusions.

|May 26, 2026
Pulmonary metastasectomy in colorectal cancer: the importance of interpreting neoadjuvant strategies in the era of modern systemic therapy.

|Apr 04, 2026
Re-evaluating treatment strategies: a closer look at the FOLFOX-nab-Paclitaxel approach in the immunotherapy era for metastatic gastric cancer.

Aysegul Merc Cetınkaya, Yusuf Ilhan

|Mar 26, 2026
Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO).

Erman Akkus, Mehmet Kayaalp, Müzeyyen Aslı Ergözoğlu

|Mar 21, 2026
Questioning the association between prophylactic antibiotics and improved prognosis in gastric cancer immunotherapy.

Yusuf Ilhan, Tolga Kosecı

|Jan 28, 2026
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkish Oncology Centers.

Halil Göksel Güzel, Arif Hakan Önder, Yusuf İlhan

Pageof 3

Frequent Collaborators

4 joint publications

Onur Yazdan Balçık

3 joint publications

Murat Araz

2 joint publications

Halil Goksel Guzel

2 joint publications

Ramazan Coşar